Can You Take Amlodipine and Metoprolol Tartrate Together?

Amlodipine and metoprolol tartrate can be taken together, and the combination is one of the more common two-drug pairings doctors prescribe for high blood pressure. The drugs work through different mechanisms that complement each other, and clinical guidelines specifically endorse pairing a beta-blocker like metoprolol with a calcium channel blocker like amlodipine. That said, the combination deserves more monitoring than either drug alone, and there are situations where it can cause problems worth knowing about.

Why These Two Drugs Get Paired

Amlodipine is a calcium channel blocker. It relaxes the smooth muscle in artery walls, widening blood vessels and lowering resistance to blood flow. Metoprolol is a beta-blocker. It slows the heart rate and reduces the force of each heartbeat, which lowers the heart’s workload and oxygen demand. Because they attack high blood pressure from two completely different angles, using them together tends to produce a larger drop in blood pressure than either one achieves alone.

There is also a practical bonus to this pairing. Amlodipine, used on its own, commonly triggers a reflex increase in heart rate: the body senses the sudden drop in vascular resistance and compensates by speeding up the heart. Metoprolol counters that reflex. The beta-blocker’s rate-slowing effect essentially smooths out the calcium channel blocker’s tendency to rev up the pulse, which makes the combination better tolerated for many people than high-dose amlodipine alone.

A 2024 review of current hypertension guidelines confirmed that including a calcium channel blocker alongside a beta-blocker is a rational combination strategy, reducing both peripheral and central blood pressure in ways that lower the burden of stroke and other complications from uncontrolled hypertension.¹

How Much Does the Combination Lower Blood Pressure?

Several trials have tested fixed-dose combinations of metoprolol and amlodipine head-to-head against each drug alone. In a randomized controlled trial known as MARS, a higher-dose combination brought systolic blood pressure down by roughly 24 points and diastolic by about 15 points over eight weeks. A lower-dose combination performed similarly, dropping systolic by about 22 points and diastolic by nearly 15. Those reductions were not statistically superior to the individual drugs in every comparison, but control rates told a more compelling story: about two-thirds of patients on the high-dose combination reached target blood pressure below 140/90, and responder rates reached the low-to-mid 90s percent, higher than what was seen with the individual components alone.²

A separate observational study in patients with essential hypertension found that blood pressure normalization climbed from about half of patients at four weeks to roughly 70% at eight weeks on the combination. Systolic blood pressure dropped by about 12% at four weeks and nearly 15% at eight weeks relative to baseline.³ The general picture across these studies is consistent: the combination works well for blood pressure, and serious adverse events directly attributable to the combination were not reported in either trial.

Benefits for Angina and Ischemia

Blood pressure is not the only reason a doctor might prescribe both drugs. The combination is also used in people with stable angina, the chest pain that occurs when the heart muscle does not get enough oxygen during exertion. Metoprolol reduces the heart’s oxygen demand by slowing the rate and force of contraction. Amlodipine helps by dilating the coronary arteries, improving blood supply. Together, they address both sides of the supply-demand mismatch that causes anginal pain.

Research on the ischemic burden, meaning the total amount of time the heart spends starved of oxygen during a day, has shown that both drugs individually cut ischemic episodes. In one study, the number of ischemic episodes over 24 hours dropped from about 30 at baseline to roughly 7 with metoprolol and about 16 with amlodipine, and the total duration of those episodes fell from 86 minutes to 15 minutes with metoprolol and 48 minutes with amlodipine.⁴ While that particular trial compared the two drugs rather than testing them in combination, the data illustrate why combining them makes clinical sense: metoprolol was the stronger anti-ischemic agent, but amlodipine added an additional mechanism that metoprolol alone does not fully cover.

There is also evidence that timing matters for the anti-anginal benefit. Research on circadian patterns of ischemia found that metoprolol’s main effect was strongest in the morning, when sympathetic nervous system activity peaks. Amlodipine’s vasodilating effect appeared to play a larger role in protecting against ischemic episodes in the evening. Combined therapy attenuated both the morning and evening surges of ischemic activity.⁵ This complementary timing pattern is one of the less obvious advantages of taking both drugs.

Side Effects Worth Watching

Every drug combination brings the side-effect profiles of both drugs to the table, and sometimes the overlap creates risks that neither drug has alone. With amlodipine and metoprolol, the main concerns fall into a few categories.

• Swollen ankles: Peripheral edema is the signature side effect of amlodipine and other calcium channel blockers. A meta-analysis of randomized trials found that roughly 11% of patients on calcium channel blockers developed peripheral edema, compared to about 3% on placebo, and the incidence climbed with higher doses and longer treatment, reaching about 24% after six months. High-dose therapy carried almost three times the edema risk of low-dose therapy.⁶ One of the rationales for adding metoprolol is that it can allow a lower amlodipine dose, which in turn may reduce this problem. In the fixed-dose combination study mentioned earlier, only about 3% of patients reported peripheral edema on the combination.³
• Low heart rate: Both amlodipine and metoprolol can slow the heart, though metoprolol is much more potent in this regard. Taking them together increases the chance of bradycardia, a resting heart rate that drops low enough to cause dizziness, fatigue, or lightheadedness. This is the main reason your doctor will typically start with moderate doses and adjust upward.
• Dizziness on standing: Orthostatic hypotension, the sudden drop in blood pressure when you stand up, is a concern with both drugs. A trial comparing metoprolol to amlodipine found that metoprolol was associated with roughly twice the odds of orthostatic hypotension based on systolic readings compared to amlodipine.⁷ Combining both drugs could compound this risk, especially in older adults or anyone already prone to drops in blood pressure upon standing.
• Fatigue and cold extremities: Beta-blockers commonly cause tiredness and cold hands or feet. Adding amlodipine does not worsen these effects and may partially help with cold extremities by dilating peripheral blood vessels, but the fatigue from metoprolol does not go away just because amlodipine is on board.

Research in older patients found that both calcium channel blockers and beta-blockers can progressively increase the frequency of orthostatic hypotension over months of treatment.⁸ This means the side-effect picture can change over time, and it is worth mentioning new dizziness or lightheadedness to your doctor even if you felt fine on the combination initially.

A Caution for Heart Failure

This is where the combination story gets more complicated. Beta-blockers, including metoprolol, are a cornerstone of heart failure treatment, and certain calcium channel blockers like amlodipine are considered safe add-ons in heart failure when additional blood pressure lowering is needed. However, the combination of both drugs in heart failure patients may not be as benign as it looks on paper.

A recent study examining hypertensive heart failure patients found that those on amlodipine combined with metoprolol had longer hospital stays compared to those on amlodipine alone, roughly 6.8 days versus 5.6 days. The association held up across multiple statistical models accounting for other confounding factors.⁹ The researchers concluded that amlodipine combined with metoprolol appeared to have an unfavorable influence on short-term outcomes in this population.

An earlier hemodynamic study in chronic heart failure patients provides some context for why this might happen. In the first dose, combining metoprolol and amlodipine produced small but statistically significant increases in pulmonary artery and wedge pressures, which are markers of fluid backing up into the lungs. Over the long term, both the combination and metoprolol alone improved cardiac output and reduced vascular resistance, but the acute hemodynamic stress of the first few doses may pose a risk for hearts that are already struggling.¹⁰

None of this means the combination is off-limits in heart failure, but it does suggest closer monitoring, cautious dose titration, and a conversation with your cardiologist about whether the specific benefit justifies the risk. For people without heart failure, this concern is much less relevant.

Tartrate Versus Succinate and the Dosing Schedule

The title of this article specifies metoprolol tartrate, and there is a practical reason to call this out. Metoprolol comes in two formulations: tartrate, which is immediate-release and typically taken twice a day, and succinate, which is extended-release and taken once a day. Both contain the same active molecule and lower blood pressure through the same mechanism. The difference is in how quickly the drug is absorbed and how long each dose lasts.

Metoprolol tartrate’s twice-daily dosing creates a less smooth blood-level curve than the sustained-release succinate formulation. You get a peak of drug activity an hour or two after each dose, followed by a gradual decline. This means that if you forget or skip a dose, you lose coverage more quickly. Amlodipine, by contrast, has a very long half-life and is taken once daily, so its blood levels stay relatively stable throughout the day.

The mismatch in dosing frequency matters for adherence. Research comparing once-daily versus twice-daily beta-blocker regimens found that patients on the once-daily schedule took the correct number of doses on about 84% of treatment days, compared to 64% for the twice-daily group. The percentage of missed doses was about 15% in the once-daily group versus 25% in the twice-daily group.¹¹ If you are already taking amlodipine once a day and adding metoprolol tartrate twice a day, be aware that the metoprolol dose is the one most likely to be forgotten. Setting a reminder for the second daily dose is a genuinely useful habit.

One thing to never do with either formulation of metoprolol: stop it suddenly. Beta-blockers should be tapered gradually under medical supervision. Abruptly stopping can trigger a rebound surge in heart rate and blood pressure that is potentially dangerous, especially if you also have coronary artery disease. Amlodipine does not carry this same rebound risk, but stopping it abruptly can still cause blood pressure to climb. If you need to discontinue either drug, your doctor will taper you off over a week or two.

What an Overdose Looks Like

Intentional or accidental overdose of both drugs together is a medical emergency. The combination can cause severe drops in blood pressure, dangerously slow heart rates, and respiratory failure. A published case report described a patient who ingested large quantities of both extended-release metoprolol and amlodipine and developed respiratory and circulatory failure severe enough to require extracorporeal membrane oxygenation, essentially a machine that does the work of the heart and lungs while the drugs are cleared from the body.¹² The patient survived, but only with aggressive intensive care intervention.

The reason this combination is particularly dangerous in overdose is that both drugs depress cardiac function through different pathways, and their effects stack. A beta-blocker overdose slows the heart and reduces contractile force; a calcium channel blocker overdose causes vasodilation and further depresses cardiac conduction. Together, they can produce a state where the heart is too slow, too weak, and the blood vessels too dilated to maintain blood flow to the brain and organs. Standard treatments include intravenous calcium, glucagon, vasopressors, and in extreme cases, mechanical circulatory support. If you or someone you know takes both drugs, keeping them in a secure location and being aware of the overdose risk is not overly cautious.

Monitoring and Practical Tips When Taking Both

If your doctor has prescribed both amlodipine and metoprolol tartrate, a few practical habits make the combination safer and more effective. Get your heart rate checked at routine visits, and learn to check your own pulse at home. A resting heart rate consistently below 50 beats per minute, especially if accompanied by dizziness or fatigue, is worth reporting. Blood pressure readings at home are also valuable: take them at the same time of day, sitting quietly, and note the values so your doctor can see the trend.

Watch your ankles. Mild swelling from amlodipine is common and usually not dangerous, but if it gets progressively worse or is accompanied by shortness of breath, that warrants a call to your doctor since fluid retention in the setting of both drugs could point to worsening cardiac function. Stand up slowly, especially in the first few weeks after starting the combination or after a dose increase. The orthostatic blood pressure drop from two blood-pressure-lowering drugs acting together can be abrupt, and a fall is a real risk for older adults.

Alcohol amplifies the blood-pressure-lowering effect of both drugs and can make dizziness and lightheadedness worse. You do not need to abstain entirely, but heavy drinking on the same evening you take both medications is a recipe for feeling faint. Grapefruit juice is sometimes flagged as a concern with amlodipine because it can slow the drug’s metabolism and increase blood levels, though the clinical significance of this interaction is modest at normal dietary amounts. There is no meaningful food interaction with metoprolol tartrate, though taking it with food does increase its absorption slightly. Consistency matters more than the specific timing relative to meals: take it the same way each day so your blood levels stay predictable.